Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July

A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. The results of this clinical trial data will directly affect MDVN, PFE, EPIX, GSK, WYE and PRAN because they are direct competitors in this area. To find out to what extent it will affect these companies and to get detailed information about the small cap company, the drug, how the drug works, how it stacks up to these other players developing drugs in this area and how this company's drug compares with the rest, read a FREE report at: http://www.newbiomedicine.com